The equation has demonstrated high discrimination and variable calibration across a range of populations.
This marks the first time in 20 years that a drug has been indicated for diabetic kidney disease treatment, according to the manufacturer.
Patients with acute on chronic kidney disease fared the worst.
Apixaban may be safer than warfarin for patients who have ESRD and who plan for anticoagulation because of AFib.
NOACs reduced risk of several adverse events compared with VKAs in a meta-analysis of chronic kidney disease patients.
LJUBLJANA, SLOVENIA – Don’t obsess about “Golden Hour” for delivering sepsis treatment bundle, expert advises.
Latest News for HOSP
Does early renal replacement therapy (RRT) initiation affect clinical outcomes in patients with severe acute kidney injury (AKI) in the setting of...
SGLT2 inhibitors and GLP-1 RAs have different effects on cardiovascular and kidney disease outcomes in patients with type 2 diabetes.
Does tamsulosin provide benefit in ureteral stone expulsion for patients who present with a symptomatic stone less than 9 mm?
Does metformin increase the risk of lactic acidosis in chronic kidney disease (CKD)?